Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  The Pakistan Stock Exchange  >  Highnoon Laboratories Limited    HINOON   PK0070701013


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Highnoon Laboratories' : Corona Combat Clinic Initiative - Press Release issued by Highnoon Laboratories Limited

share with twitter share with LinkedIn share with facebook
05/13/2020 | 02:06pm EDT

May 13, 2020 (PPI-OT)

Following is the text of press release issued by Highnoon Laboratories Limited


In pursuit of safeguarding the healthcare providers amidst the coronavirus pandemic, Highnoon Laboratories Limited extends its support to the healthcare community by launching the Corona Combat Clinic initiative across Pakistan.

Corona Combat Clinic initiative is focused on providing state-of-the-art protection equipment to healthcare centers all over Pakistan. This will not only help protect doctors, nurses, support staff, and patients but will also enable these help centers to implement guidelines issued by DRAP and WHO. Additionally, disinfection and sanitization services along with air quality improvement initiatives are also in place at these health centers and protocols have been established to ensure strict compliance with these guidelines.

Many healthcare professionals and practitioners have appreciated the Corona Combat Clinic initiative for the safety and sanitization of front-line medical heroes: "Highnoon is among the pioneers in considering the safety of doctors on priority. This clinic disinfection along with providing protective equipment is really commendable," remarked a senior consultant Neurophysician practicing in Rawalpindi.

Another senior Cardiologist praised this noble effort and commented, "In this pandemic of Covid19, I appreciate the efforts of Highnoon for being on the frontline for the safety of doctors and patients." The National Institute of Cardiovascular Diseases (NICVD) Karachi has also appreciated Highnoon's efforts for "generous spray services".

Chairman Highnoon, Tausif Khan commented, "Highnoon is making efforts to ensure that patients seeking healthcare are provided the healthcare they need. Patients are unable to get the medical attention they urgently need because of the lockdowns and also the fact that patients are avoiding visits to the doctors out of fear of catching Coronavirus. Medical intervention should not be delayed under any circumstances. Through Corona Combat Clinic initiative, online services have also been rolled out to encourage patients to seek medical advice at home if they desire."

CEO Highnoon, Dr Adeel Abbas said, "Highnoon group has a proven track record of fulfilling a promise i.e. to act as a responsible corporate entity whose focus has always been to give back to the society which is also in line with our Chairman's vision who has a long history of philanthropic contributions."

Highnoon as part of its continuous CSR efforts, supports Pakistan Red Crescent Society, thalassemia societies like Fatimid foundation, Sundus foundation, and other NGOs. "Safety and well-being are of utmost importance to us and we will continue to support our frontline warriors against covid19. We are 100 percent committed to our promise of contributing to a healthier nation for a prosperous Pakistan," he further added.

For more information, contact:Highnoon Laboratories LimitedRegistered, Head Office and Plant17.5 KM, Multan Road, Lahore - 53700, PakistanTel: +92-42-37510023-27Fax: +92-42-37510037UAN: +92-42-111-000-465Email: info@highnoon.com.pkWebsite: http://www.highnoon-labs.com/


© Pakistan Press International, source Asianet-Pakistan

share with twitter share with LinkedIn share with facebook
06/08HIGHNOON LABORATORIES : Credit/Dispatch of Bonus Share Certificates of Highnoon ..
06/05HIGHNOON LABORATORIES : Credit of Final Cash Dividend of Highnoon Laboratories L..
06/01HIGHNOON LABORATORIES : Transaction of 2,100 shares of Highnoon Laboratories Lim..
05/18HIGHNOON LABORATORIES : Transaction of 8,550 shares of Highnoon Laboratories Lim..
05/13HIGHNOON LABORATORIES' : Corona Combat Clinic Initiative - Press Release issued ..
05/13HIGHNOON LABORATORIES : launches Corona Combat Clinic Initiative
05/01HIGHNOON LABORATORIES : Financial results of Highnoon Laboratories Limited for Q..
04/30HIGHNOON LABORATORIES : Transmission of Quarterly Report for the Period Ended Ma..
04/22HIGHNOON LABORATORIES : Board of directors meeting of Highnoon Laboratories Limi..
04/21HIGHNOON LABORATORIES : Transmission of Annual Report for the Year Ended Decembe..
More news
Sales 2019 9 048 M 56,2 M 56,2 M
Net income 2019 1 001 M 6,22 M 6,22 M
Net cash 2019 706 M 4,39 M 4,39 M
P/E ratio 2019 16,9x
Yield 2019 2,42%
Capitalization 21 626 M 134 M 134 M
EV / Sales 2018 1,24x
EV / Sales 2019 1,79x
Nbr of Employees 1 825
Free-Float 100%
Duration : Period :
Highnoon Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Adeel Abbas Haideri Chief Executive Officer & Executive Director
Tausif Ahmad Khan Chairman
Sajjad Hafeez Butt Executive Director-Operations
Javed Hussain Executive Director-Finance
Ashfaq Alidina Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON-0.43%382 350
ROCHE HOLDING AG-5.29%280 884
PFIZER INC.-2.55%212 162
MERCK & CO., INC.-12.23%201 909
NOVARTIS AG-16.78%185 999